New chemo cocktail shows promise for rare bone cancer
NCT ID NCT03011528
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 36 times
Summary
This study tested a more intense chemotherapy plan for people aged 2 to 50 with Ewing sarcoma that has spread beyond the lungs. The goal was to see if this approach could help more patients become cancer-free for at least 18 months. The treatment combined high-dose chemotherapy with a stem cell transplant to try to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EWING SARCOMA FAMILY OF TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bordeaux Chu
Bordeaux, 33076, France
-
CHRU Montpellier - Hôpital A. de Villeneuve
Montpellier, 34295, France
-
CHU Grenoble Alpes
Grenoble, 38043, France
-
CHU Hôpital Sud
Rennes, 35056, France
-
Chr Felix Guyon
La Réunion, Saint Denis, 97400, France
-
LILLE Centre Oscar Lambret
Lille, 59000, France
-
LYON Centre Léon Bérard
Lyon, 69000, France
-
Marseille Chu
Marseille, 13000, France
-
NANCY Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
-
Nancy Chu
Vandœuvre-lès-Nancy, 54511, France
-
Nantes Chu
Nantes, 44000, France
-
PARIS Institut Curie
Paris, 75005, France
-
PARIS Trousseau
Paris, 75012, France
-
Strasbourg Chu
Strasbourg, 67098, France
-
TOULOUSE Institut Claudius Regaud
Toulouse, 31059, France
-
Toulouse Chu
Toulouse, 31059, France
-
VILLEJUIF Institut Gustave Roussy
Villejuif, 94805, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.